FELICIA CHRETIEN: Open Payments
NPI 1295328102 · BRAZORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 10 payments from 7 companies in 2025. Trend: 2023 $580 · 2024 $234 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $161 |
| Neurocrine BioSciences, Inc. | 2 | $143 |
| Viatris Specialty LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| ABBVIE INC. | 1 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, INGREZZA, YUPELRI, Ozempic, CAPLYTA, QULIPTA, Qelbree.
Industry payments across TX — which companies pay providers there.
